Literature DB >> 15582570

Production of research-grade antibody by in vivo electroporation of DNA-encoding target protein.

Fumiaki Okahara1, Kouichi Itoh, Michihiro Ebihara, Masao Kobayashi, Hiroki Maruyama, Yasunori Kanaho, Tomohiko Maehama.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15582570     DOI： 10.1016/j.ab.2004.09.018

Source DB:  PubMed          Journal:  Anal Biochem        ISSN： 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  5 in total

1.  Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation.

Authors:  Fumiaki Okahara; Kouichi Itoh; Akira Nakagawara; Makoto Murakami; Yasunori Kanaho; Tomohiko Maehama
Journal:  Mol Biol Cell       Date:  2006-09-13       Impact factor: 4.138

2.  Nucleolar stress induces ubiquitination-independent proteasomal degradation of PICT1 protein.

Authors:  Tomohiko Maehama; Kohichi Kawahara; Miki Nishio; Akira Suzuki; Kentaro Hanada
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

3.  Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.

Authors:  Masato Sasaki; Kohichi Kawahara; Miki Nishio; Koshi Mimori; Ryunosuke Kogo; Koichi Hamada; Bunsho Itoh; Jia Wang; Yukako Komatsu; Yong Ryoul Yang; Hiroki Hikasa; Yasuo Horie; Takayuki Yamashita; Takehiko Kamijo; Yanping Zhang; Yan Zhu; Carol Prives; Toru Nakano; Tak Wah Mak; Takehiko Sasaki; Tomohiko Maehama; Masaki Mori; Akira Suzuki
Journal:  Nat Med       Date:  2011-07-31       Impact factor: 53.440

4.  GLTSCR2/PICT-1, a putative tumor suppressor gene product, induces the nucleolar targeting of the Kaposi's sarcoma-associated herpesvirus KS-Bcl-2 protein.

Authors:  Inna Kalt; Tatyana Borodianskiy-Shteinberg; Adi Schachor; Ronit Sarid
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

5.  PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression.

Authors:  R Uchi; R Kogo; K Kawahara; T Sudo; T Yokobori; H Eguchi; K Sugimachi; T Maehama; M Mori; A Suzuki; S Komune; K Mimori
Journal:  Br J Cancer       Date:  2013-09-17       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.